• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大成人肥胖临床实践指南中的医学化驱动因素。

Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.

机构信息

Department of Sociology, University of New Brunswick, 3 Bailey Drive, P.O. Box 4400, Fredericton, New Brunswick, E3B 5A3, Canada.

Flourish Kirribilli, 13/1 Broughton St, Kirribilli, NSW, 2061, Australia.

出版信息

Can J Public Health. 2022 Oct;113(5):743-748. doi: 10.17269/s41997-022-00662-4. Epub 2022 Jul 15.

DOI:10.17269/s41997-022-00662-4
PMID:35838981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481752/
Abstract

The new Canadian Adult Obesity Clinical Practice Guidelines frame higher body weight as a chronic, relapsing disease requiring comprehensive medical treatment pathways. In this commentary, we will demonstrate how a process called pharmaceuticalization is informing the new guidelines. We join those questioning the normalization of industry and medical collaboration and interrogate whether the new guidelines meaningfully address stigma.

摘要

新的加拿大成人肥胖临床实践指南将较高的体重定义为一种需要全面医疗治疗途径的慢性、复发性疾病。在这篇评论中,我们将展示制药化过程如何为新指南提供信息。我们加入了那些对行业和医疗合作正常化提出质疑的人,并探讨新指南是否真正解决了耻辱问题。

相似文献

1
Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.加拿大成人肥胖临床实践指南中的医学化驱动因素。
Can J Public Health. 2022 Oct;113(5):743-748. doi: 10.17269/s41997-022-00662-4. Epub 2022 Jul 15.
2
Fatness, medicalization, and stigma: on the need to do better.肥胖、医学化与污名化:论改进的必要性。
Narrat Inq Bioeth. 2014 Summer;4(2):117-23. doi: 10.1353/nib.2014.0053.
3
The 'side effects' of medicalization: a meta-analytic review of how biogenetic explanations affect stigma.医学化的“副作用”:生物遗传解释如何影响污名的元分析综述。
Clin Psychol Rev. 2013 Aug;33(6):782-94. doi: 10.1016/j.cpr.2013.06.002. Epub 2013 Jun 18.
4
Risk factor medicalization, hubris, and the obesity disease.风险因素医学化、傲慢自大与肥胖症
Narrat Inq Bioeth. 2014 Summer;4(2):143-6. doi: 10.1353/nib.2014.0043.
5
Obesity Prevention and Management Strategies in Canada: Shifting Paradigms and Putting People First.加拿大肥胖预防与管理策略:转变观念,以人为本。
Curr Obes Rep. 2018 Jun;7(2):89-96. doi: 10.1007/s13679-018-0309-8.
6
Inequities in healthcare: a review of bias and discrimination in obesity treatment.医疗保健中的不平等:肥胖治疗中的偏见和歧视综述。
Can J Diabetes. 2013 Jun;37(3):205-9. doi: 10.1016/j.jcjd.2013.03.362. Epub 2013 May 29.
7
Discrimination in the health care system among higher-weight adults: evidence from a Canadian national cross-sectional survey.高体重成年人在医疗保健系统中受到歧视:来自加拿大全国横断面调查的证据。
Health Promot Chronic Dis Prev Can. 2020 Nov/Dec;40(11-12):329-335. doi: 10.24095/hpcdp.40.11/12.01.
8
Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization.促进疾病以促进药物:制药业在促进良医和滥医中的作用。
Br J Clin Pharmacol. 2022 Jan;88(1):34-39. doi: 10.1111/bcp.14835. Epub 2021 Mar 31.
9
Canadian Senate Report on Obesity: Focusing on Individual Behaviours versus Social Determinants of Health May Promote Weight Stigma.加拿大参议院关于肥胖问题的报告:关注个人行为而非健康的社会决定因素可能会加剧体重歧视。
J Obes. 2018 Jul 2;2018:8645694. doi: 10.1155/2018/8645694. eCollection 2018.
10
The Incomplete Medicalization of Obesity: Physician Office Visits, Diagnoses, and Treatments, 1996-2014.肥胖的不完全医学化:1996-2014 年医生诊疗所访视、诊断和治疗。
Public Health Rep. 2019 Mar/Apr;134(2):141-149. doi: 10.1177/0033354918813102. Epub 2019 Feb 22.

本文引用的文献

1
Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.企业是否在重新定义疾病和健康?糖尿病的流行、目标数字和重磅药物。
J Bioeth Inq. 2021 Sep;18(3):477-497. doi: 10.1007/s11673-021-10119-x. Epub 2021 Sep 6.
2
Treatment Outcomes and Trajectories of Change in Patients Attributing Their Eating Disorder Onset to Anti-obesity Messaging.归因于抗肥胖信息而发病的患者的治疗结果和变化轨迹。
Psychosom Med. 2021 Sep 1;83(7):777-786. doi: 10.1097/PSY.0000000000000962.
3
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.一缕阳光:医生-行业关系的透明度还不够。
J Gen Intern Med. 2021 Oct;36(10):3194-3198. doi: 10.1007/s11606-021-06657-0. Epub 2021 Mar 10.
4
Benefits and Risks of Bariatric Surgery in Adults: A Review.成人减肥手术的获益与风险:综述
JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567.
5
Obesity in adults: a clinical practice guideline.成人肥胖:临床实践指南。
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
6
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.报告加拿大临床实践指南制定者的财务利益冲突:描述性研究。
CMAJ. 2020 Jun 8;192(23):E617-E625. doi: 10.1503/cmaj.191737.
7
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - .美国临床内分泌医师协会和美国内分泌学会关于2型糖尿病综合管理算法的共识声明 -
Endocr Pract. 2020 Jan;26(1):107-139. doi: 10.4158/CS-2019-0472.
8
A critical analysis of obesity prevention policies and strategies.肥胖预防政策与策略的批判性分析
Can J Public Health. 2017 Sep;108(5-6):e598-e608. doi: 10.17269/CJPH.108.6044. Epub 2017 Sep 1.
9
Knowledge brokering: (mis)aligning population knowledge with care of fat bodies.知识中介:(错误)将人口知识与肥胖人群的护理联系起来。
Can J Public Health. 2018 Dec;109(5-6):643-652. doi: 10.17269/s41997-018-0147-1. Epub 2018 Nov 21.
10
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.产业资助对研究议程的影响:范围综述。
Am J Public Health. 2018 Nov;108(11):e9-e16. doi: 10.2105/AJPH.2018.304677. Epub 2018 Sep 25.